Ellenbogen, A.; Hauser, R.A.; Patel, A.T.; McAllister, P.; Gross, T.M.; Kazerooni, R.; Gallagher, C.J.; Hollander, D.A.
Efficacy Remaining at Time of Requested Re-Treatment for Cervical Dystonia: A Potential New Treatment Paradigm with DaxibotulinumtoxinA. Toxins 2025, 17, 133.
https://doi.org/10.3390/toxins17030133
AMA Style
Ellenbogen A, Hauser RA, Patel AT, McAllister P, Gross TM, Kazerooni R, Gallagher CJ, Hollander DA.
Efficacy Remaining at Time of Requested Re-Treatment for Cervical Dystonia: A Potential New Treatment Paradigm with DaxibotulinumtoxinA. Toxins. 2025; 17(3):133.
https://doi.org/10.3390/toxins17030133
Chicago/Turabian Style
Ellenbogen, Aaron, Robert A. Hauser, Atul T. Patel, Peter McAllister, Todd M. Gross, Rashid Kazerooni, Conor J. Gallagher, and David A. Hollander.
2025. "Efficacy Remaining at Time of Requested Re-Treatment for Cervical Dystonia: A Potential New Treatment Paradigm with DaxibotulinumtoxinA" Toxins 17, no. 3: 133.
https://doi.org/10.3390/toxins17030133
APA Style
Ellenbogen, A., Hauser, R. A., Patel, A. T., McAllister, P., Gross, T. M., Kazerooni, R., Gallagher, C. J., & Hollander, D. A.
(2025). Efficacy Remaining at Time of Requested Re-Treatment for Cervical Dystonia: A Potential New Treatment Paradigm with DaxibotulinumtoxinA. Toxins, 17(3), 133.
https://doi.org/10.3390/toxins17030133
